Revelation Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

레벌레이션 바이오사이언시스NASDAQ:REVB · Nasdaq · Healthcare · sector #17

$0.8281+10.09%

2026-10-07 close

Revelation Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$8M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy